Money Never Sleeps Radio with Louis Velazquez

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

The approval gives Novo Nordisk a head start over chief rival Eli Lilly, which is racing to launch its own obesity pill.

Leave a Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright, All Rights Reserved © UCWE Media